This summer there was a series of trades in the NFL at the most important position, quarterback. What made these trades unusual was it wasn’t a bunch of second stringers changing uniforms but starters. Well it looks like the wacky world is following the NFL as per a story in Reuters;
“Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will join Sanofi to stem a decline in prices in the French drugmaker's anti-diabetics and established drugs.
In a statement on Thursday, Germany's Bayer said Weinand . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.